These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 78950)
21. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells. Wright SC; Bonavida B J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139 [No Abstract] [Full Text] [Related]
22. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. Yoshida R; Yoneda Y; Kuriyama M; Kubota T J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111 [TBL] [Abstract][Full Text] [Related]
23. Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells. Holden HT; Oldham RK; Ortaldo JR; Herberman RB J Natl Cancer Inst; 1977 Mar; 58(3):611-22. PubMed ID: 839557 [TBL] [Abstract][Full Text] [Related]
24. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
25. Adjuvant effect of poly(A:U) upon T cell-mediated in vitro cytotoxic allograft responses. Wagner H; Cone RE Cell Immunol; 1974 Mar; 10(3):394-403. PubMed ID: 4281721 [No Abstract] [Full Text] [Related]
26. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro. Jones B; Jones TC; Roitt IM Immunology; 1977 Apr; 32(4):591-9. PubMed ID: 415967 [TBL] [Abstract][Full Text] [Related]
27. Study of cell-mediated immunity in B77 tumor bearing rats by 51chromium release assay. Kalafut F; Novotná L; Valentová N Neoplasma; 1981; 28(6):689-95. PubMed ID: 7339497 [TBL] [Abstract][Full Text] [Related]
28. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction. Senik A; Gomard E; Plata F; Levy JP Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585 [No Abstract] [Full Text] [Related]
29. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages. Jones B; Jones TC Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994 [TBL] [Abstract][Full Text] [Related]
30. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas. Leclerc JC; Gomard E; Levy JP Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690 [No Abstract] [Full Text] [Related]
31. In vitro detection of cell-mediated immunity to individual tumor-specific antigens of chemically induced BALB/c fibrosarcomas. Carbone G; Colombo MP; Sensi ML; Cernuschi A; Parmiani G Int J Cancer; 1983 Apr; 31(4):483-9. PubMed ID: 6832855 [TBL] [Abstract][Full Text] [Related]
32. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens. Kedar E; Bonavida B J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889 [TBL] [Abstract][Full Text] [Related]
33. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice. Germain RN; Williams RM; Benacerraf B Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice. Fuyama S; Yamamoto H; Fujii Y; Arai S Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480 [TBL] [Abstract][Full Text] [Related]
35. Preferential induction of serum blocking activity and enhancement of skin allograft by soluble alloantigen. Rao VS; Bonavida B; Zighelboim J; Fahey JL Transplantation; 1974 Jun; 17(6):568-75. PubMed ID: 4597923 [No Abstract] [Full Text] [Related]
36. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells. Williams RM; Germain RN; Benacerraf B J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740 [TBL] [Abstract][Full Text] [Related]
37. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures. Hurrell SM; Zarling JM J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084 [TBL] [Abstract][Full Text] [Related]
38. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Herberman RB; Nunn ME; Holden HT; Lavrin DH Int J Cancer; 1975 Aug; 16(2):230-9. PubMed ID: 1080480 [TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells. Ting C-C ; Bushar GS; Rodrigues D; Herberman RB J Immunol; 1975 Nov; 115(5):1351-6. PubMed ID: 170343 [TBL] [Abstract][Full Text] [Related]
40. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. I. Basic parameters: baseline controls, target cells, and methods of calculation. Ting CC; Park JY; Nunn ME; Herberman RB J Natl Cancer Inst; 1977 Feb; 58(2):323-30. PubMed ID: 833880 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]